Qantas in the skies
Image: Qantas Ltd
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Macquarie Bank (MQG) has released fresh analysis looking over the global travel sector, highlighting that wealthier consumers are still travelling at levels not far off pre-COVID.

While airline revenue growth is declining everywhere (except for the Americas), the Australia & New Zealand region remains an internationally significant source of demand for recreational flights.

Corporate flight demand also continues to lag.

On home soil

Australian travel spend is above 2019 levels. For this reason, travel management companies have actually outperformed the airlines themselves in Australia.

Ticket purchases being made by Australian recreational tourists are higher than in 2022, though, not dramatically above last year.

Analysts noted that leisure travel is surprisingly resilient when compared to the larger macroeconomic backdrop, which has not been framed by optimism whatsoever in recent months.

What does this mean for your stocks?

Macquarie Analysts recommended investors considered ASX-listed companies Flight Centre (FLT), Qantas (QAN) and Webjet (WEB).

Webjet and Flight Centre are expected to continue to benefit from resilient recreational travel but analysts noted that recessionary threats dangle over the heads of investors.

Should a hard recession trigger, analysts expect leisure travel to suffer, perhaps more in line with what one would predict to already be the case.

More From The Market Online

EV Resources confirms 81% antimony recovery at the Tecomatlán processing plant

EV Resources has successfully tested metallurgical flotation for third-party feedstock at its Tecomatlán Processing Plant in…
The Market Online Video

Codeifai (ASX:CDE) talks product evolution, AI, and what’s next for the business

HotCopper speaks to Codefai executive director and COO Martin Ross about the ASX-listed company entering a…

FDA allows AFT’s injectable iron project clinical study to proceed

AFT Pharmaceuticals has obtained positive FDA) approval to proceed with the next stage of its injectable…

Iluka Resources signs rare earths offtake agreement and satisfies financing condition

Iluka Resources has concluded a binding, multi-year agreement for the supply of magnet rare earth oxides…